Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JBL | Status Update | 06/05/22 | 1 | 1.3K | |||
|
|||||||
JBL | Ann:Company Removed from Official List (Price Sensitive) | 04/11/20 | 5 | 5.3K | |||
|
|||||||
JBL | Ann:Continued Suspension - Failure to lodge Audited Annual Financials - 30 June 2020 (Price... | 01/10/20 | 0 | 737 | |||
|
|||||||
JBL | Ann:Director's passing | 25/09/20 | 5 | 5.2K | |||
|
|||||||
JBL | Ann:Continued Suspension - Failure to release Preliminary Final Report for 30 June 2020 (Price... | 14/09/20 | 0 | 680 | |||
|
|||||||
JBL | Ann:Continued Suspension - Non-payment of 2020 - 2021 Annual Listing Fees (Price Sensitive) | 17/08/20 | 0 | 811 | |||
|
|||||||
JBL | Ann:Continued Suspension - Non-lodgement of Half Yearly Financial Statements - 31 December 2019... | 21/05/20 | 5 | 4.9K | |||
|
|||||||
JBL | Ann:Director resignation | 16/01/20 | 0 | 1.8K | |||
|
See All Discussions